MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6603-512-521$20.00
Mol Pharmacol 66:512-521, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carney, S. A.
Right arrow Articles by Heideman, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carney, S. A.
Right arrow Articles by Heideman, W.

2,3,7,8-Tetrachlorodibenzo-p-dioxin Activation of the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Pathway Causes Developmental Toxicity through a CYP1A-Independent Mechanism in Zebrafish

Sara A. Carney, Richard E. Peterson , and Warren Heideman

Molecular and Environmental Toxicology Center (S.A.C., R.E.P., W.H.) and School of Pharmacy (R.E.P., W.H.), University of Wisconsin, Madison, Wisconsin

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that dimerizes with ARNT to mediate responses to compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). TCDD and other AHR agonists cause toxic responses in early life stages of fish, including the zebrafish, Danio rerio. The most well characterized target gene for the AHR/aryl hydrocarbon receptor nuclear translocator (ARNT) dimer is a cytochrome P450, CYP1A. Induction of CYP1A by TCDD has been correlated with certain toxic responses in developing zebrafish and has been postulated to mediate these responses. To determine whether CYP1A is the important downstream effector enzyme for the AHR/ARNT pathway, we used morpholino oligonucleotides (MOs) to block induction of CYP1A in response to TCDD in zebrafish embryos. Although the zfcyp1a-MO effectively prevented CYP1A up-regulation, it did not prevent the signs of developmental toxicity, including pericardial edema, slowed blood flow, craniofacial malformation, and defects in erythropoiesis. We conclude that the important target for the AHR/ARNT pathway in developing zebrafish exposed to TCDD is not zfcyp1a. This suggests an alternative model in which TCDD-activated AHR/ARNT disrupts the normal process of growth and development by altering programs of gene expression or function.


Received February 23, 2004; accepted May 21, 2004.

Address correspondence to: Warren Heideman, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705. E-mail: wheidema{at}wisc.edu




This article has been cited by other articles:


Home page
Toxicol SciHome page
M. J. Jenny, S. I. Karchner, D. G. Franks, B. R. Woodin, J. J. Stegeman, and M. E. Hahn
Distinct Roles of Two Zebrafish AHR Repressors (AHRRa and AHRRb) in Embryonic Development and Regulating the Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Toxicol. Sci., August 1, 2009; 110(2): 426 - 441.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. C. Grimes, K. N. Erwin, H. A. Stadt, G. L. Hunter, H. A. Gefroh, H.-J. Tsai, and M. L. Kirby
PCB126 Exposure Disrupts ZebraFish Ventricular and Branchial but Not Early Neural Crest Development
Toxicol. Sci., November 1, 2008; 106(1): 193 - 205.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. M. Billiard, J. N. Meyer, D. M. Wassenberg, P. V. Hodson, and R. T. Di Giulio
Nonadditive effects of PAHs on Early Vertebrate Development: mechanisms and implications for risk assessment
Toxicol. Sci., September 1, 2008; 105(1): 5 - 23.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H.-C. Yin, H.-P. Tseng, H.-Y. Chung, C.-Y. Ko, W.-S. Tzou, D. R. Buhler, and C.-H. Hu
Influence of TCDD on Zebrafish CYP1B1 Transcription during Development
Toxicol. Sci., May 1, 2008; 103(1): 158 - 168.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. E. S. Bohonowych, B. Zhao, A. Timme-Laragy, D. Jung, R. T. Di Giulio, and M. S. Denison
Newspapers and Newspaper Ink Contain Agonists for the Ah Receptor
Toxicol. Sci., April 1, 2008; 102(2): 278 - 290.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. E. Jonsson, M. J. Jenny, B. R. Woodin, M. E. Hahn, and J. J. Stegeman
Role of AHR2 in the Expression of Novel Cytochrome P450 1 Family Genes, Cell Cycle Genes, and Morphological Defects in Developing Zebra Fish Exposed to 3,3',4,4',5-Pentachlorobiphenyl or 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Toxicol. Sci., November 1, 2007; 100(1): 180 - 193.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. A. Andreasen, L. K. Mathew, C. V. Lohr, R. Hasson, and R. L. Tanguay
Aryl Hydrocarbon Receptor Activation Impairs Extracellular Matrix Remodeling during Zebra Fish fin Regeneration
Toxicol. Sci., January 1, 2007; 95(1): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. S. Antkiewicz, R. E. Peterson, and W. Heideman
Blocking Expression of AHR2 and ARNT1 in Zebrafish Larvae Protects Against Cardiac Toxicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Toxicol. Sci., November 1, 2006; 94(1): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. M. Billiard, A. R. Timme-Laragy, D. M. Wassenberg, C. Cockman, and R. T. Di Giulio
The Role of the Aryl Hydrocarbon Receptor Pathway in Mediating Synergistic Developmental Toxicity of Polycyclic Aromatic Hydrocarbons to Zebrafish
Toxicol. Sci., August 1, 2006; 92(2): 526 - 536.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. A. Carney, J. Chen, C. G. Burns, K. M. Xiong, R. E. Peterson, and W. Heideman
Aryl Hydrocarbon Receptor Activation Produces Heart-Specific Transcriptional and Toxic Responses in Developing Zebrafish
Mol. Pharmacol., August 1, 2006; 70(2): 549 - 561.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. A. Andreasen, L. K. Mathew, and R. L. Tanguay
Regenerative Growth Is Impacted by TCDD: Gene Expression Analysis Reveals Extracellular Matrix Modulation
Toxicol. Sci., July 1, 2006; 92(1): 254 - 269.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. L. Prasch, R. L. Tanguay, V. Mehta, W. Heideman, and R. E. Peterson
Identification of Zebrafish ARNT1 Homologs: 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity in the Developing Zebrafish Requires ARNT1
Mol. Pharmacol., March 1, 2006; 69(3): 776 - 787.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. C. Volz, D. E. Hinton, J. M. Law, and S. W. Kullman
Dynamic Gene Expression Changes Precede Dioxin-Induced Liver Pathogenesis in Medaka Fish
Toxicol. Sci., February 1, 2006; 89(2): 524 - 534.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. K. Heiden, R. J. Hutz, and M. J. Carvan III
Accumulation, Tissue Distribution, and Maternal Transfer of Dietary 2,3,7,8,-Tetrachlorodibenzo-p-Dioxin: Impacts on Reproductive Success of Zebrafish
Toxicol. Sci., October 1, 2005; 87(2): 497 - 507.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. J. Hill, H. Teraoka, W. Heideman, and R. E. Peterson
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
Toxicol. Sci., July 1, 2005; 86(1): 6 - 19.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. M. Handley-Goldstone, M. W. Grow, and J. J. Stegeman
Cardiovascular Gene Expression Profiles of Dioxin Exposure in Zebrafish Embryos
Toxicol. Sci., May 1, 2005; 85(1): 683 - 693.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. S. Antkiewicz, C. G. Burns, S. A. Carney, R. E. Peterson, and W. Heideman
Heart Malformation Is an Early Response to TCDD in Embryonic Zebrafish
Toxicol. Sci., April 1, 2005; 84(2): 368 - 377.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics